Trial
NCT00776555
Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Shire
Collaborators
—
Condition
Healthy
Intervention
Lisdexamfetamine Dimesylate
Why stopped
The study was stopped by the sponsor based on a non-safety related business priority decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-09